Stand-alone middle meningeal artery embolization in chronic subdural hematoma patient presenting cognitive decline: a case report
DOI:
https://doi.org/10.13181/mji.cr.247366Keywords:
chronic subdural hematoma, cognitive impairment, MMA embolizationAbstract
Chronic subdural hematoma (cSDH) is a neurological disorder that commonly occurs in the elderly with high morbidity and mortality. Current treatment for cSDH consists of conservative therapy, surgical evacuation, and endovascular therapy, or a combination of all the methods. Endovascular therapy for cSDH management involving middle meningeal artery embolization (MMAE) has become a promising therapeutic option for clinicians as it offers a minimally invasive, safe, and effective choice with a low recurrence rate. MMAE using particles can also be performed in frail elderly patients who cannot undergo large craniotomy procedures. We presented a case of a subdural hematoma patient with cognitive decline using a therapeutic strategy of stand-alone MMAE, which resulted in cognitive function improvement
Downloads
References
Yang W, Huang J. Chronic subdural hematoma: epidemiology and natural history. Neurosurg Clin N Am. 2017;28(2):205−10. https://doi.org/10.1016/j.nec.2016.11.002
Balser D, Farooq S, Mehmood T, Reyes M, Samadani U. Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations. J Neurosurg. 2015;123(5):1209−15. https://doi.org/10.3171/2014.9.JNS141550
Nouri A, Gondar R, Schaller K, Meling T. Chronic subdural hematoma (cSDH): a review of the current state of the art. Brain Spine. 2021;1:100300. https://doi.org/10.1016/j.bas.2021.100300
Kolias AG, Chari A, Santarius T, Hutchinson PJ. Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol. 2014;10(10):570−8. https://doi.org/10.1038/nrneurol.2014.163
Ishikawa E, Yanaka K, Sugimoto K, Ayuzawa S, Nose T. Reversible dementia in patients with chronic subdural hematomas. J Neurosurg. 2002;96(4):680−3. https://doi.org/10.3171/jns.2002.96.4.0680
Kawasaki Y, Fujiki M, Ooba H, Sugita K, Hikawa T, Abe T, et al. Short latency afferent inhibition associated with cortical compression and memory impairment in patients with chronic subdural hematoma. Clin Neurol Neurosurg. 2012;114(7):976−80. https://doi.org/10.1016/j.clineuro.2012.02.037
Désir LL, D'Amico R, Link T, Silva D, Ellis JA, Doron O, et al. Middle meningeal artery embolization and the treatment of a chronic subdural hematoma. Cureus. 2021;13(10):e18868. https://doi.org/10.7759/cureus.18868
Shlobin NA, Kedda J, Wishart D, Garcia RM, Rosseau G. Surgical management of chronic subdural hematoma in older adults: a systematic review. J Gerontol A Biol Sci Med Sci. 2021;76(8):1454−62. https://doi.org/10.1093/gerona/glaa293
Drake M, Ullberg T, Nittby H, Marklund N, Wassélius J. Swedish trial on embolization of middle meningeal artery versus surgical evacuation in chronic subdural hematoma (SWEMMA)-a national 12-month multi-center randomized controlled superiority trial with parallel group assignment, open treatment allocation and blinded clinical outcome assessment. Trials. 2022;23(1):926. https://doi.org/10.1186/s13063-022-06842-4
Di Cristofori A, Remida P, Patassini M, Piergallini L, Buonanno R, Bruno R, et al. Middle meningeal artery embolization for chronic subdural hematomas. A systematic review of the literature focused on indications, technical aspects, and future possible perspectives. Surg Neurol Int. 2022;13:94. https://doi.org/10.25259/SNI_911_2021
Ku JC, Dmytriw AA, Essibayi MA, Banihashemi MA, Vranic JE, Ghozy S, et al. Embolic agent choice in middle meningeal artery embolization as primary or adjunct treatment for chronic subdural hematoma: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2023;44(3):297−302. https://doi.org/10.3174/ajnr.A7796
Ban SP, Hwang G, Byoun HS, Kim T, Lee SU, Bang JS, et al. Middle meningeal artery embolization for chronic subdural hematoma. Radiology. 2018;286(3):992−9. https://doi.org/10.1148/radiol.2017170053
Hanif H, Farook S, Suriya SS, Gondal MU, Bilal MI, Sheikh AB. Middle meningeal artery embolization: a paradigm shift in approach of chronic subdural hematoma. J Community Hosp Intern Med Perspect. 2022;12(5):25−35. https://doi.org/10.55729/2000-9666.1086
Zhang J; Chinese Society of Neurosurgery, Chinese Medical Association, Chinese Neurosurgical Critical Care Specialist Council, Collaborational Group of Chinese Neurosurgical Translational and Evidence-based Medicine. Expert consensus on drug treatment of chronic subdural hematoma. Chin Neurosurg J. 2021;7(1):47. https://doi.org/10.1186/s41016-021-00263-z
Sioutas GS, Vivanco-Suarez J, Shekhtman O, Matache IM, Salem MM, Burkhardt JK, et al. Liquid embolic agents for middle meningeal artery embolization in chronic subdural hematoma: institutional experience with systematic review and metaanalysis. Interv Neuroradiol. 2023:15910199231183132. https://doi.org/10.1177/15910199231183132
Krothapalli N, Patel S, Fayad M, Elmashad A, Killory B, Bruno C, et al. Outcomes of particle versus liquid embolic materials used in middle meningeal artery embolization for the treatment of chronic subdural hematoma. World Neurosurg. 2023;173:e27−36. https://doi.org/10.1016/j.wneu.2023.01.077
Cohen-Cohen S, Jabal MS, Rinaldo L, Savastano LE, Lanzino G, Cloft H, et al. Middle meningeal artery embolization for chronic subdural hematoma: a single-center experience and predictive modeling of outcomes. Neuroradiol J. 2024;37(2):192−8. https://doi.org/10.1177/19714009231224431
Khorasanizadeh M, Shutran M, Garcia A, Enriquez-Marulanda A, Moore J, Ogilvy CS, et al. Middle meningeal artery embolization for treatment of chronic subdural hematomas: does selection of embolized branches affect outcomes? J Neurosurg. 2022;138(6):1494−502. https://doi.org/10.3171/2022.9.JNS221663
Scoville JP, Joyce E, A Tonetti D, Bounajem MT, Thomas A, Ogilvy CS, et al. Radiographic and clinical outcomes with particle or liquid embolic agents for middle meningeal artery embolization of nonacute subdural hematomas. Interv Neuroradiol. 2023;29(6):683−90. https://doi.org/10.1177/15910199221104631
Seok JH, Kim JH, Kwon TH, Byun J, Yoon WK. Middle meningeal artery embolization for chronic subdural hematoma in elderly patients at high risk of surgical treatment. J Cerebrovasc Endovasc Neurosurg. 2023;25(1):28−35. https://doi.org/10.7461/jcen.2022.E2022.08.003
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Yusmahenry Galindra, Beny Rilianto, Ricky Gusanto Kurniawan, Bambang Tri Prasetyo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with Medical Journal of Indonesia agree to the following terms:
- Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.
